Investigational Ceftobiprole Just As Effective As Daptomycin For Bacterial Bloodstream Infections Caused By Staphylococcus Aureus Bacteremia, Trial Demonstrates

MedPage Today (10/24, Hein) reports, “Investigational ceftobiprole was just as effective as daptomycin for bacterial bloodstream infections caused by Staphylococcus aureus bacteremia, the phase III ERADICATE trial demonstrated.” In a “randomized head-to-h...